PharmaRoth Labs, Inc. (ROTH)

[old biohf guy]

So far nobody has made any real money from this stock, except for perhaps a few savyy traders. The real investors and the company executives will make their money when the good news breaks, namely the results from the Mexico clinical trials, and significan sales start and the share price goes up accordingly.

If the clinical trial results are anything close to what previous testing showed, then India will approve and sales will start with Canagen as the distributor.

THIS is the reason people are invested in Roth - not for the $147 in the bank. Surely, this is a high-risk / high-reward stock and its not for everyone.

Everyone should do their own DD and invest accordingly.